Joy Wolfram

Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.

Hesperetin: an inhibitor of the transforming growth factor-β (TGF-β) signaling pathway.

Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors.

Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells.

High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.

Live-cell single-molecule imaging reveals clathrin and caveolin-1 dependent docking of SMAD4 at the cell membrane.

Shrinkage of pegylated and non-pegylated liposomes in serum.

Liposomal chemotherapeutics.

Polyarginine induces an antitumor immune response through binding to toll-like receptor 4.

Differences in the aerobic capacity of flight muscles between butterfly populations and species with dissimilar flight abilities.

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

The nano-plasma interface: Implications of the protein corona.

Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics.

Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy.

Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes.

Mechanistic features of nanodiamonds in the lapping of magnetic heads.

Safety of Nanoparticles in Medicine.

The impact of lubricants on the precision lapping process.

Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.